Variant report
Variant | nsv462316 |
---|---|
Chromosome Location | chr5:99268324-99290311 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:47)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:47 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:99275443-99275530 | K562 | blood: | n/a | chr5:99275488-99275499 |
2 | CEBPB | chr5:99275346-99275667 | A549 | lung: | n/a | chr5:99275488-99275499 |
3 | CEBPB | chr5:99280745-99280940 | H1-hESC | embryonic stem cell: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
4 | CEBPB | chr5:99281714-99281914 | HepG2 | liver: | n/a | chr5:99281715-99281726 chr5:99281776-99281787 |
5 | CEBPB | chr5:99275354-99275668 | IMR90 | lung: | n/a | chr5:99275488-99275499 |
6 | CEBPB | chr5:99287782-99288036 | A549 | lung: | n/a | chr5:99287911-99287922 |
7 | CEBPB | chr5:99280601-99280858 | HepG2 | liver: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
8 | CEBPB | chr5:99287769-99288059 | HepG2 | liver: | n/a | chr5:99287911-99287922 |
9 | CEBPB | chr5:99287763-99288089 | IMR90 | lung: | n/a | chr5:99287911-99287922 |
10 | CEBPB | chr5:99275330-99275682 | HepG2 | liver: | n/a | chr5:99275488-99275499 |
11 | CEBPB | chr5:99281660-99281902 | A549 | lung: | n/a | chr5:99281715-99281726 chr5:99281776-99281787 |
12 | CEBPB | chr5:99280572-99280892 | A549 | lung: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
13 | CEBPB | chr5:99280607-99280936 | IMR90 | lung: | n/a | chr5:99280757-99280766 chr5:99280756-99280767 chr5:99280757-99280766 |
14 | CTCF | chr5:99287120-99287270 | GM12864 | blood: | n/a | n/a |
15 | E2F4 | chr5:99269153-99269495 | MCF10A-Er-Src | breast: | n/a | chr5:99269164-99269173 |
16 | EBF1 | chr5:99272555-99272980 | GM12878 | blood: | n/a | chr5:99272773-99272784 |
17 | EBF1 | chr5:99270596-99270892 | GM12878 | blood: | n/a | chr5:99270748-99270759 |
18 | FOS | chr5:99272325-99272987 | HUVEC | blood vessel: | n/a | chr5:99272756-99272767 |
19 | IRF1 | chr5:99277028-99277044 | K562 | blood: | n/a | n/a |
20 | JUN | chr5:99272606-99272642 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | JUN | chr5:99281721-99281849 | HepG2 | liver: | n/a | chr5:99281773-99281786 |
22 | JUN | chr5:99282401-99282538 | HepG2 | liver: | n/a | n/a |
23 | KAP1 | chr5:99269643-99269913 | K562 | blood: | n/a | n/a |
24 | MAZ | chr5:99272816-99272825 | HepG2 | liver: | n/a | n/a |
25 | MYC | chr5:99285729-99285816 | MCF-7 | breast: | n/a | n/a |
26 | MYC | chr5:99277073-99277212 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | NFYB | chr5:99288286-99288478 | Hela-S3 | cervix: | n/a | n/a |
28 | POLR2A | chr5:99285791-99286112 | MCF-7 | breast: | n/a | n/a |
29 | POLR2A | chr5:99278837-99279003 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr5:99268584-99268884 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr5:99273578-99273670 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr5:99273725-99273736 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr5:99273196-99273423 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | POLR2A | chr5:99269664-99269856 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr5:99285987-99286144 | MCF-7 | breast: | n/a | n/a |
36 | POLR2A | chr5:99286967-99287178 | MCF-7 | breast: | n/a | n/a |
37 | POLR2A | chr5:99285897-99285912 | MCF-7 | breast: | n/a | n/a |
38 | SRF | chr5:99276170-99276629 | HCT-116 | colon: | n/a | chr5:99276419-99276437 |
39 | SRF | chr5:99276204-99276678 | H1-hESC | embryonic stem cell: | n/a | chr5:99276419-99276437 |
40 | SRF | chr5:99276220-99276698 | ECC-1 | luminal epithelium: | n/a | chr5:99276419-99276437 |
41 | SRF | chr5:99276330-99276523 | HepG2 | liver: | n/a | chr5:99276419-99276437 |
42 | SRF | chr5:99276201-99276647 | H1-hESC | embryonic stem cell: | n/a | chr5:99276419-99276437 |
43 | SRF | chr5:99276335-99276491 | HepG2 | liver: | n/a | chr5:99276419-99276437 |
44 | STAT3 | chr5:99283420-99283491 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | STAT3 | chr5:99287489-99287663 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | STAT3 | chr5:99284087-99284232 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | TCF7L2 | chr5:99273349-99273918 | HepG2 | liver: | n/a | chr5:99273791-99273801 chr5:99273696-99273703 chr5:99273788-99273802 chr5:99273787-99273803 chr5:99273787-99273803 |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:99281632..99283428-chr5:99288358..99290129,2 | MCF-7 | breast: | |
2 | chr5:99279070..99281321-chr9:113352239..113355129,2 | MCF-7 | breast: | |
3 | chr5:99272528..99274253-chr5:99280354..99282185,2 | K562 | blood: | |
4 | chr5:99272528..99274253-chr5:99280354..99282185,2 | K562 | blood: | |
5 | chr5:99281632..99283428-chr5:99288358..99290129,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250391 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536746682 | chr5:99281409-99281410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549016497 | chr5:99281464-99281465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148863562 | chr5:99281483-99281484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534785780 | chr5:99281540-99281541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs193198867 | chr5:99281611-99281612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577984355 | chr5:99281612-99281613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370054685 | chr5:99281633-99281634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538973942 | chr5:99281652-99281653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577209738 | chr5:99281669-99281670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558178628 | chr5:99281755-99281756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4235630 | chr5:99281756-99281757 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs543460068 | chr5:99281758-99281759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371391553 | chr5:99281823-99281824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562177916 | chr5:99281867-99281868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143398971 | chr5:99281869-99281870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78484741 | chr5:99281879-99281880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4235631 | chr5:99281990-99281991 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs113042997 | chr5:99285744-99285745 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs899056 | chr5:99285749-99285750 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs149605688 | chr5:99285791-99285792 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs144349019 | chr5:99285802-99285803 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs553192864 | chr5:99285803-99285804 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs541951753 | chr5:99285880-99285881 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs553685080 | chr5:99285887-99285888 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs575053628 | chr5:99285944-99285945 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs571865380 | chr5:99285959-99285960 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs183131806 | chr5:99285994-99285995 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs148777754 | chr5:99286002-99286003 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs370630472 | chr5:99286034-99286035 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs144910339 | chr5:99286037-99286038 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs73775961 | chr5:99286084-99286085 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs562940591 | chr5:99286095-99286096 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs530133743 | chr5:99286118-99286119 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs543799884 | chr5:99286184-99286185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548617130 | chr5:99286209-99286210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368028839 | chr5:99286218-99286219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546222105 | chr5:99286219-99286220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147967285 | chr5:99286293-99286294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552827694 | chr5:99286307-99286308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73775962 | chr5:99286330-99286331 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs72767588 | chr5:99286346-99286347 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs188460164 | chr5:99286379-99286380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568096677 | chr5:99286398-99286399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535111366 | chr5:99286408-99286409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543408518 | chr5:99286416-99286417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564969622 | chr5:99286474-99286475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571827368 | chr5:99286542-99286543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs564941987 | chr5:99286543-99286544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527405309 | chr5:99286559-99286560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545569985 | chr5:99286581-99286582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:99281400-99282000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr5:99286000-99286200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:99286000-99287200 | Enhancers | Spleen | Spleen |
4 | chr5:99286200-99293400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |